Logo image of MANH

MANHATTAN ASSOCIATES INC (MANH) Stock Fundamental Analysis

USA - NASDAQ:MANH - US5627501092 - Common Stock

175.49 USD
-4.64 (-2.58%)
Last: 11/6/2025, 8:00:01 PM
175.49 USD
0 (0%)
After Hours: 11/6/2025, 8:00:01 PM
Fundamental Rating

7

Taking everything into account, MANH scores 7 out of 10 in our fundamental rating. MANH was compared to 284 industry peers in the Software industry. Both the health and profitability get an excellent rating, making MANH a very profitable company, without any liquidiy or solvency issues. MANH has a correct valuation and a medium growth rate. With these ratings, MANH could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MANH was profitable.
MANH had a positive operating cash flow in the past year.
In the past 5 years MANH has always been profitable.
MANH had a positive operating cash flow in each of the past 5 years.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

Looking at the Return On Assets, with a value of 28.10%, MANH belongs to the top of the industry, outperforming 97.18% of the companies in the same industry.
Looking at the Return On Equity, with a value of 69.86%, MANH belongs to the top of the industry, outperforming 97.89% of the companies in the same industry.
The Return On Invested Capital of MANH (60.21%) is better than 99.30% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MANH is significantly above the industry average of 11.85%.
The 3 year average ROIC (55.23%) for MANH is below the current ROIC(60.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 28.1%
ROE 69.86%
ROIC 60.21%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

With an excellent Profit Margin value of 20.25%, MANH belongs to the best of the industry, outperforming 83.80% of the companies in the same industry.
MANH's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 25.28%, MANH belongs to the top of the industry, outperforming 89.79% of the companies in the same industry.
In the last couple of years the Operating Margin of MANH has grown nicely.
MANH's Gross Margin of 56.54% is on the low side compared to the rest of the industry. MANH is outperformed by 64.08% of its industry peers.
MANH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.28%
PM (TTM) 20.25%
GM 56.54%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MANH is creating value.
The number of shares outstanding for MANH has been reduced compared to 1 year ago.
The number of shares outstanding for MANH has been reduced compared to 5 years ago.
There is no outstanding debt for MANH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MANH has an Altman-Z score of 17.58. This indicates that MANH is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 17.58, MANH belongs to the top of the industry, outperforming 93.31% of the companies in the same industry.
MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.58
ROIC/WACC5.43
WACC11.08%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.31 indicates that MANH should not have too much problems paying its short term obligations.
The Current ratio of MANH (1.31) is comparable to the rest of the industry.
MANH has a Quick Ratio of 1.31. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
MANH has a Quick ratio (1.31) which is in line with its industry peers.
MANH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.59% over the past year.
Measured over the past years, MANH shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.14% on average per year.
MANH shows a small growth in Revenue. In the last year, the Revenue has grown by 4.10%.
Measured over the past years, MANH shows a quite strong growth in Revenue. The Revenue has been growing by 11.02% on average per year.
EPS 1Y (TTM)9.59%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%0.74%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%3.42%

3.2 Future

The Earnings Per Share is expected to grow by 17.76% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.08% on average over the next years. This is quite good.
EPS Next Y4.11%
EPS Next 2Y6.86%
EPS Next 3Y10.09%
EPS Next 5Y17.76%
Revenue Next Year3.49%
Revenue Next 2Y5.24%
Revenue Next 3Y6.6%
Revenue Next 5Y8.08%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 34.89, MANH can be considered very expensive at the moment.
61.27% of the companies in the same industry are more expensive than MANH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of MANH to the average of the S&P500 Index (25.67), we can say MANH is valued slightly more expensively.
MANH is valuated quite expensively with a Price/Forward Earnings ratio of 32.49.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MANH is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of MANH to the average of the S&P500 Index (31.86), we can say MANH is valued inline with the index average.
Industry RankSector Rank
PE 34.89
Fwd PE 32.49
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

MANH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MANH is cheaper than 68.66% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MANH indicates a somewhat cheap valuation: MANH is cheaper than 69.01% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 31.85
EV/EBITDA 38.49
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MANH may justify a higher PE ratio.
PEG (NY)8.48
PEG (5Y)1.58
EPS Next 2Y6.86%
EPS Next 3Y10.09%

0

5. Dividend

5.1 Amount

MANH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (11/6/2025, 8:00:01 PM)

After market: 175.49 0 (0%)

175.49

-4.64 (-2.58%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-21 2025-10-21/amc
Earnings (Next)01-26 2026-01-26/amc
Inst Owners103.5%
Inst Owner Change0.72%
Ins Owners1.24%
Ins Owner Change-4.68%
Market Cap10.61B
Revenue(TTM)1.07B
Net Income(TTM)216.01M
Analysts78.82
Price Target230.9 (31.57%)
Short Float %2.72%
Short Ratio3.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.65%
Min EPS beat(2)13.36%
Max EPS beat(2)13.93%
EPS beat(4)4
Avg EPS beat(4)12.31%
Min EPS beat(4)8.28%
Max EPS beat(4)13.93%
EPS beat(8)8
Avg EPS beat(8)17.09%
EPS beat(12)12
Avg EPS beat(12)22.76%
EPS beat(16)16
Avg EPS beat(16)22.85%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.26%
Revenue beat(8)5
Avg Revenue beat(8)1.01%
Revenue beat(12)9
Avg Revenue beat(12)2.52%
Revenue beat(16)13
Avg Revenue beat(16)2.9%
PT rev (1m)-1.01%
PT rev (3m)10.84%
EPS NQ rev (1m)-1.4%
EPS NQ rev (3m)-1.4%
EPS NY rev (1m)0.4%
EPS NY rev (3m)4.94%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-0.72%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 34.89
Fwd PE 32.49
P/S 9.95
P/FCF 31.85
P/OCF 30.57
P/B 34.32
P/tB 42.97
EV/EBITDA 38.49
EPS(TTM)5.03
EY2.87%
EPS(NY)5.4
Fwd EY3.08%
FCF(TTM)5.51
FCFY3.14%
OCF(TTM)5.74
OCFY3.27%
SpS17.64
BVpS5.11
TBVpS4.08
PEG (NY)8.48
PEG (5Y)1.58
Graham Number24.06
Profitability
Industry RankSector Rank
ROA 28.1%
ROE 69.86%
ROCE 73.21%
ROIC 60.21%
ROICexc 211.53%
ROICexgc 520.48%
OM 25.28%
PM (TTM) 20.25%
GM 56.54%
FCFM 31.23%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
ROICexc(3y)379.42%
ROICexc(5y)338.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)67.16%
ROCE(5y)58.04%
ROICexgc growth 3YN/A
ROICexgc growth 5Y6.89%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y14.68%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
F-Score7
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 217.07%
Cap/Sales 1.31%
Interest Coverage 250
Cash Conversion 125.71%
Profit Quality 154.25%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 17.58
F-Score7
WACC11.08%
ROIC/WACC5.43
Cap/Depr(3y)106.14%
Cap/Depr(5y)79.88%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.65%
Profit Quality(3y)134%
Profit Quality(5y)144.89%
High Growth Momentum
Growth
EPS 1Y (TTM)9.59%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%0.74%
EPS Next Y4.11%
EPS Next 2Y6.86%
EPS Next 3Y10.09%
EPS Next 5Y17.76%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%3.42%
Revenue Next Year3.49%
Revenue Next 2Y5.24%
Revenue Next 3Y6.6%
Revenue Next 5Y8.08%
EBIT growth 1Y3.83%
EBIT growth 3Y24.89%
EBIT growth 5Y17.68%
EBIT Next Year8.29%
EBIT Next 3Y8.86%
EBIT Next 5Y11.24%
FCF growth 1Y60.27%
FCF growth 3Y16.48%
FCF growth 5Y16.8%
OCF growth 1Y62.89%
OCF growth 3Y16.79%
OCF growth 5Y14.96%

MANHATTAN ASSOCIATES INC / MANH FAQ

Can you provide the ChartMill fundamental rating for MANHATTAN ASSOCIATES INC?

ChartMill assigns a fundamental rating of 7 / 10 to MANH.


What is the valuation status of MANHATTAN ASSOCIATES INC (MANH) stock?

ChartMill assigns a valuation rating of 3 / 10 to MANHATTAN ASSOCIATES INC (MANH). This can be considered as Overvalued.


Can you provide the profitability details for MANHATTAN ASSOCIATES INC?

MANHATTAN ASSOCIATES INC (MANH) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for MANH stock?

The Price/Earnings (PE) ratio for MANHATTAN ASSOCIATES INC (MANH) is 34.89 and the Price/Book (PB) ratio is 34.32.


Can you provide the financial health for MANH stock?

The financial health rating of MANHATTAN ASSOCIATES INC (MANH) is 9 / 10.